NCT00718549 2018-08-20A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL)Hoffmann-La RochePhase 3 Completed128 enrolled 10 charts
NCT00764517 2017-12-11Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's LymphomaOHSU Knight Cancer InstitutePhase 2 Completed57 enrolled 14 charts
NCT00003174 2014-04-24Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaBarbara Ann Karmanos Cancer InstitutePhase 1 Completed80 enrolled
NCT00004904 2012-06-04Stem Cell Transplantation in Treating Patients With Hematologic CancerNorthwestern UniversityPhase 1 Completed
NCT00072007 2012-05-15Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLLSwiss Cancer InstitutePhase 2 Completed43 enrolled